Neptune Wellness Solutions PE Ratio 2010-2023 | NEPTF
Current and historical p/e ratio for Neptune Wellness Solutions (NEPTF) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Neptune Wellness Solutions PE ratio as of May 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Neptune Wellness Solutions PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-29 | 0.01 | 0.00 | |
| 2023-12-31 | 0.53 | $-106.72 | 0.00 |
| 2023-09-30 | 1.32 | $-100.18 | 0.00 |
| 2023-06-30 | 5.88 | $-256.40 | 0.00 |
| 2023-03-31 | 21.60 | $-273.20 | 0.00 |
| 2022-12-31 | 12.60 | $-436.40 | 0.00 |
| 2022-09-30 | 60.80 | $-564.67 | 0.00 |
| 2022-06-30 | 56.00 | $-490.99 | 0.00 |
| 2022-03-31 | 311.36 | $-602.05 | 0.00 |
| 2021-12-31 | 574.00 | $-797.20 | 0.00 |
| 2021-09-30 | 846.44 | $-1,300.70 | 0.00 |
| 2021-06-30 | 1638.00 | $-1,426.57 | 0.00 |
| 2021-03-31 | 1834.00 | $-1,412.59 | 0.00 |
| 2020-12-31 | 2184.00 | $-1,398.60 | 0.00 |
| 2020-09-30 | 2954.00 | $-699.30 | 0.00 |
| 2020-06-30 | 3920.00 | $-727.27 | 0.00 |
| 2020-03-31 | 1638.00 | $-685.31 | 0.00 |
| 2019-12-31 | 3850.00 | $-419.58 | 0.00 |
| 2019-09-30 | 4984.00 | $-545.45 | 0.00 |
| 2019-06-30 | 6090.00 | $-349.65 | 0.00 |
| 2019-03-31 | 4466.00 | $-321.68 | 0.00 |
| 2018-12-31 | 3556.00 | $-153.85 | 0.00 |
| 2018-09-30 | 5432.00 | $-97.90 | 0.00 |
| 2018-06-30 | 4340.00 | $-55.94 | 0.00 |
| 2016-11-30 | 1428.00 | $13.99 | 102.10 |
| 2016-08-31 | 1371.86 | $13.99 | 98.09 |
| 2016-05-31 | 1694.00 | $-13.99 | 0.00 |
| 2016-03-31 | 1400.00 | $-41.96 | 0.00 |
| 2016-02-29 | 1567.86 | $-125.87 | 0.00 |
| 2015-12-31 | 1498.00 | $-265.73 | 0.00 |
| 2015-09-30 | 1540.00 | $-251.75 | 0.00 |
| 2015-06-30 | 1806.00 | $-433.57 | 0.00 |
| 2015-03-31 | 2268.00 | $-447.55 | 0.00 |
| 2014-12-31 | 2660.00 | $-307.69 | 0.00 |
| 2014-09-30 | 2702.00 | $-475.52 | 0.00 |
| 2014-06-30 | 3864.00 | $-349.65 | 0.00 |
| 2014-03-31 | 3472.00 | $-363.64 | 0.00 |
| 2013-12-31 | 4060.00 | $-377.62 | 0.00 |
| 2013-09-30 | 4452.00 | $-195.80 | 0.00 |
| 2013-06-30 | 4550.00 | $-405.59 | 0.00 |
| 2013-03-31 | 3528.00 | $-419.58 | 0.00 |
| 2013-02-28 | 3640.00 | $-433.57 | 0.00 |
| 2012-12-31 | 2814.00 | $-447.55 | 0.00 |
| 2012-09-30 | 5530.00 | $-167.83 | 0.00 |
| 2012-06-30 | 6635.86 | $-111.89 | 0.00 |
| 2012-03-31 | 4410.00 | $-125.87 | 0.00 |
| 2011-12-31 | 4088.00 | $-41.96 | 0.00 |
| 2011-09-30 | 3556.00 | $27.97 | 127.13 |
| 2011-06-30 | 5250.00 | $97.90 | 53.63 |
| 2011-03-31 | 3136.00 | $153.85 | 20.38 |
| 2010-12-31 | 3472.00 | $83.92 | 41.37 |
| 2010-09-30 | 2940.00 | $97.90 | 30.03 |
| 2010-06-30 | 1596.00 | $27.97 | 57.06 |
| 2010-03-31 | 2772.00 | $-41.96 | 0.00 |
| 2009-12-31 | 2884.00 | $-41.96 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.053B |
| Neptune Wellness Solutions Inc. is a diversified and fully integrated health and wellness company. It provides turnkey product development and supply chain solutions to business customers across several health and wellness verticals, including legal cannabis and hemp, nutraceuticals and white label consumer packaged goods. Neptune Wellness Solutions Inc. is headquartered in Laval, Quebec. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.137B | 27.79 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $145.939B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $128.884B | 0.00 |
| Medtronic (MDT) | Ireland | $105.694B | 14.98 |
| Haleon (HLN) | United Kingdom | $51.038B | 29.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.182B | 0.00 |
| ResMed (RMD) | United States | $35.941B | 27.00 |
| GE HealthCare Technologies (GEHC) | United States | $32.753B | 15.55 |
| Agilent Technologies (A) | United States | $32.296B | 20.98 |
| Terumo (TRUMY) | Japan | $27.790B | 36.10 |
| Insulet (PODD) | United States | $22.791B | 89.46 |
| Koninklijke Philips (PHG) | Netherlands | $21.581B | 15.51 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.467B | 11.86 |
| Baxter (BAX) | United States | $15.754B | 11.76 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.622B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.194B | 21.55 |
| Lantheus Holdings (LNTH) | United States | $5.225B | 13.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.175B | 18.65 |
| Perrigo (PRGO) | Ireland | $3.730B | 9.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Haemonetics (HAE) | United States | $3.259B | 14.85 |
| Envista Holdings (NVST) | United States | $3.129B | 26.00 |
| GN Store Nord (GNNDY) | Denmark | $2.215B | 18.35 |
| QuidelOrtho (QDEL) | United States | $2.080B | 14.30 |
| LeMaitre Vascular (LMAT) | United States | $1.832B | 40.94 |
| AtriCure (ATRC) | United States | $1.687B | 0.00 |
| Neogen (NEOG) | United States | $1.348B | 17.25 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.165B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| BioLife Solutions (BLFS) | United States | $1.060B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.000B | 12.78 |
| InMode (INMD) | Israel | $0.922B | 9.29 |
| CeriBell (CBLL) | United States | $0.615B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.604B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.582B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.502B | 4.17 |
| Tilray Brands (TLRY) | Canada | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.461B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.333B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Sanara MedTech (SMTI) | United States | $0.261B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| ZimVie (ZIMV) | United States | $0.250B | 11.35 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Cerus (CERS) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| Biote (BTMD) | United States | $0.197B | 5.53 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.44 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.52 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Agape ATP (ATPC) | $0.088B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |